{"lastClose": 5.090000152587891, "len": 962, "date": "2023-01-27", "alpha_1": -0.7327468440627745, "beta_1": 0.8909092120391389, "drawup_1": 0.7155424508464454, "natr_1": 17.469212616330903, "sup_1": -1.0386377983776423, "res_1": 0.7046495400004845, "bullPattern_1": [], "bearPattern_1": ["CLOSINGMARUBOZU", "HIKKAKE"], "rsi_1": 46.57534619407248, "adx_1": 17.241387850483072, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.5046199611654754, "stratHoldAlpha_1": 250.57491338871554, "stratHoldDrawdown_1": -0.7357679280492505, "alpha_3mo": -0.3939903720877542, "beta_3mo": 1.5139378660849525, "drawup_3mo": 0.185682424944281, "natr_3mo": 17.469212616330903, "sup_3mo": -0.09626720517100072, "res_3mo": 0.007858507211826052, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 58.51851982671382, "adx_3mo": 49.46366223109175, "drawdown_3mo": -0.2358974593056159, "stratHoldSharpe_3mo": -0.019563782183548824, "stratHoldAlpha_3mo": 250.98917639824876, "stratHoldDrawdown_3mo": -0.21428573544086804, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 415168654, "Name": "NGM Biopharmaceuticals Inc.", "Sector": "Health Care", "IPO Year": 2019.0, "alpha%_1": 0.02370010490302922, "beta%_1": 0.43037771166282657, "drawup%_1": 0.7084799855295597, "natr%_1": 0.9999999974105043, "drawdown%_1": 0.01790242655265713, "stratHoldSharpe%_1": 0.14765701321664315, "stratHoldAlpha%_1": 0.024856842751088865, "stratHoldDrawdown%_1": 0.020063577481670387, "alpha%_3mo": 0.18299040452118187, "beta%_3mo": 0.8053877417199415, "drawup%_3mo": 0.34295260140261996, "natr%_3mo": 0.999999994651641, "drawdown%_3mo": 0.22959157221359894, "stratHoldSharpe%_3mo": 0.25012398950642245, "stratHoldAlpha%_3mo": 0.274056991276315, "stratHoldDrawdown%_3mo": 0.2293491228554152}